Here is the link:
https://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2022.205.1_MeetingAbstracts.A1083
Note that it was a poster presentation only.
When you read the study abstract it seems quite under-whelming to me, and doesn't seem to correlate to the hype of the announcement, but I am no expert.
Ann: 4DMedical clinical trial results presented at ATS, page-5
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
52.0¢ |
Change
-0.005(0.95%) |
Mkt cap ! $213.4M | |||
| Open | High | Low | Value | Volume |
| 52.0¢ | 53.5¢ | 51.0¢ | $175.2K | 337.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 173020 | 51.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 52.0¢ | 162258 | 3 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |